Johnson & Johnson said late Thursday that its single-shot COVID-19 vaccine showed promise against the highly contagious Delta variant in a laboratory study.
Johnson & Johnson said late Thursday that its single-shot COVID-19 vaccine showed promise against the highly contagious Delta variant in a laboratory study.